EATG is pleased to share this new resource: Access to highly effective hepatitis C treatment in Portugal – A Community Perspective. This case study demonstrates how a country with limited resources, negotiating within the existing financial framework, confidential price negotiations and with ambitious objectives, can yield practical results.
The document presents an example of successful community engagement and activism for highly effective hepatitis C treatment, led by the Grupo de Ativistas em Tratamentos (GAT). It summarises the price and reimbursement negotiations in Portugal. Importantly, it also identifies lessons and recommendations that readers may find helpful in advocating in their own countries for universal (or as close as possible) access to these and other life-saving drugs.
The document explores several key components of successful negotiations process in a context of confidential price negotiations, including the need for community empowerment as well as effective multisectoral collaboration across PLHCV, clinicians, hospital administrators, academics, media contacts and decision makers.
The PWG recommends this document and hopes it will prove useful to others who are working for speedy access to state-of-the-art medicines in their own countries.
Click here for the case study: Community advocacy for access to DAA’s in Portugal 12.2016
Click here for the appendix and additional considerations: Access to DAA’s Portugal – appendix